EUVIMEDEUVIMED entdecken
LeserbriefKohortenstudieOpen Access

No increased risk of breast or gynecologic malignancies in women exposed to spironolactone for dermatologic conditions: A retrospective cohort study

Rachel C Hill, Yu Wang, Bilal Shaikh, Shari R Lipner

Journal of the American Academy of Dermatology · 2024

DOI: 10.1016/j.jaad.2024.02.030 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Journal of the American Academy of Dermatology, 2024. Verfasst von Rachel C Hill und 3 weiteren Autor:innen. Beteiligte Einrichtung: Weill Cornell Medical College, New York, New York. Hauptthemen laut MEDLINE: Breast Neoplasms, Spironolactone, Genital Neoplasms, Female, Skin Diseases. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 4 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCATS NIH HHS, National Center for Advancing Translational Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsSpironolactoneGenital Neoplasms, FemaleSkin DiseasesHumansFemaleRetrospective StudiesMiddle AgedAdultAgedRisk AssessmentMineralocorticoid Receptor AntagonistsCohort Studies

Stichwörter der Autor:innen

acnebreast cancerdermatologygynecologic cancerhair losshirsutismmedical dermatologyspironolactone

Substanzen

SpironolactoneMineralocorticoid Receptor Antagonists

Autor:innen und Institutionen

  • Weill Cornell Medical College, New York, New York.
  • Department of Dermatology, Wake Forest School of Medicine, Wake Forest, North Carolina.
  • Division of Biostatistics, Department of Population Health Sciences, Weill Cornell Medicine, New York, New York.
  • Department of Dermatology, Weill Cornell Medicine, New York, New York. Electronic address: shl9032@med.cornell.edu.

Förderung

  • NCATS NIH HHS
  • National Center for Advancing Translational Sciences

Zitieren

APA

Hill, R. C., Wang, Y., Shaikh, B., & Lipner, S. R. (2024). No increased risk of breast or gynecologic malignancies in women exposed to spironolactone for dermatologic conditions: A retrospective cohort study. Journal of the American Academy of Dermatology. https://doi.org/10.1016/j.jaad.2024.02.030

Vancouver

Hill RC, Wang Y, Shaikh B, Lipner SR. No increased risk of breast or gynecologic malignancies in women exposed to spironolactone for dermatologic conditions: A retrospective cohort study. Journal of the American Academy of Dermatology. 2024. doi:10.1016/j.jaad.2024.02.030

BibTeX
@article{Hill2024,
  author = {Hill, Rachel C and Wang, Yu and Shaikh, Bilal and Lipner, Shari R},
  title = {No increased risk of breast or gynecologic malignancies in women exposed to spironolactone for dermatologic conditions: A retrospective cohort study},
  journal = {Journal of the American Academy of Dermatology},
  year = {2024},
  doi = {10.1016/j.jaad.2024.02.030}
}
Kostenlos starten →